
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
HDACs as an emerging target in endocrine tumors: a comprehensive review
E. Klieser, Bettina Neumayer, Pietro Di Fazio, et al.
Expert Review of Endocrinology & Metabolism (2023) Vol. 18, Iss. 2, pp. 143-154
Closed Access | Times Cited: 3
E. Klieser, Bettina Neumayer, Pietro Di Fazio, et al.
Expert Review of Endocrinology & Metabolism (2023) Vol. 18, Iss. 2, pp. 143-154
Closed Access | Times Cited: 3
Showing 3 citing articles:
Dual-target inhibitors of colchicine binding site for cancer treatment
Lu Lu, Keke Li, Jiaxin Pu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116543-116543
Closed Access | Times Cited: 5
Lu Lu, Keke Li, Jiaxin Pu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116543-116543
Closed Access | Times Cited: 5
Design and optimization of novel Tetrahydro-β-carboline-based HDAC inhibitors with potent activities against tumor cell growth and metastasis
Shule Fan, Zeyi Wan, Yuhua Qu, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 114, pp. 129986-129986
Closed Access
Shule Fan, Zeyi Wan, Yuhua Qu, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 114, pp. 129986-129986
Closed Access
New insights into possible HDAC inhibitor resistance in DLBCL - Comment on 'defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma' by Havas et al.
Tobias Kiesslich, Christian Mayr, Dino Bekric, et al.
Translational Oncology (2023) Vol. 44, pp. 101820-101820
Open Access
Tobias Kiesslich, Christian Mayr, Dino Bekric, et al.
Translational Oncology (2023) Vol. 44, pp. 101820-101820
Open Access